Perspective - Pharmaceutical Bioprocessing (2025) Volume 13, Issue 6
Advanced Foam Control Strategies in Bioprocessing
Dr. Maria Kowalska*
Dept. of Process Optimization, Warsaw Institute of Tech, Poland
- *Corresponding Author:
- Dr. Maria Kowalska
Dept. of Process Optimization, Warsaw Institute of Tech, Poland
E-mail: m.kowalska@wit.pl
Received: 01-Nov-2025, Manuscript No. fmpb-26-184977; Editor assigned: 03- Nov -2025, PreQC No. fmpb-26-184977 (PQ); Reviewed: 17- Nov -2025, QC No. fmpb-26-184977; Revised: 22- Nov -2025, Manuscript No. fmpb-26-184977 (R); Published: 29- Nov -2025, DOI: 10.37532/2048-9145.2025.13(6). 263-264
Introduction
Foam formation is a common challenge in bioprocessing, particularly in microbial and mammalian cell culture systems where aeration, agitation, and surface-active components promote bubble stabilization. Excessive foam can lead to product loss, contamination risks, sensor malfunction, and reduced process control [1,2]. Traditional foam control relies heavily on chemical antifoam agents, which may negatively impact oxygen transfer, cell viability, and downstream purification. Advanced foam control strategies aim to mitigate foam formation more effectively while minimizing adverse effects on process performance and product quality.
Discussion
Modern foam control approaches integrate physical, chemical, and digital solutions. Mechanical foam breakers, such as rotating disks or foam traps, disrupt foam structure without introducing chemical additives. These systems are particularly valuable in processes where antifoam agents interfere with downstream operations, such as chromatography or filtration. Improved bioreactor design, including optimized impeller geometry and gas sparging systems, also reduces foam generation by controlling bubble size and gas dispersion [3,4].
Chemical strategies have evolved toward more selective and process-compatible antifoam formulations. Silicone-free and biodegradable antifoams are increasingly used to reduce environmental impact and downstream interference. Controlled and localized antifoam dosing, guided by real-time foam detection, minimizes overuse and preserves mass transfer efficiency.
Digitalization has enabled intelligent foam monitoring and control. Advanced foam sensors, including conductivity probes and optical systems, detect foam formation in real time. These sensors can be integrated with automated control systems to trigger precise antifoam addition or mechanical interventions only when needed. Machine learning models are emerging as powerful tools to predict foam formation based on process parameters such as agitation speed, gas flow rate, and media composition [5].
Despite these advances, challenges remain in balancing foam suppression with optimal oxygen transfer and cell performance. Process-specific customization is often required, as foam behavior varies widely across organisms and operating conditions. Validation of advanced control systems and their impact on product quality is also critical to meet regulatory expectations.
Conclusion
Advanced foam control strategies represent an important evolution in bioprocessing technology. By combining improved bioreactor design, selective antifoam formulations, real-time sensing, and automated control, these strategies reduce operational risks while maintaining high process performance. Although challenges related to system integration and process variability persist, continued innovation is improving reliability and efficiency. As bioprocesses become more intensified and automated, advanced foam control will remain essential for ensuring robust, scalable, and high-quality biomanufacturing operations.
References
- Sinclair JR (2019) Importance of a One Health approach in advancing global health security and the Sustainable Development Goals. Revue scientifique et technique 38: 145-154.
- Aslam B, Khurshid M, Arshad MI, Muzammil S, Rasool M, et al. (2021) Antibiotic resistance: one health one world outlook. Frontiers in Cellular and Infection Microbiology 1153.
- Doherty R, Madigan S, Warrington G, Ellis J (2019) Sleep and nutrition interactions: implications for athletes. Nutrients 11:822.
- Jagannath A, Taylor L, Wakaf Z, Vasudevan SR, Foster RG, et al. (2017) The genetics of circadian rhythms, sleep and health. Hum Mol Genet 26:128-138.
- Somberg J (2009) Health Care Reform. Am J Ther 16: 281-282.
